We provide rescue medicines typically used in emergency rooms and intensive care units to treat patients for whom there are limited treatment options. We are dedicated to delivering quality medicines that make a real difference to patients and their families through the development, manufacture, and commercialisation of pharmaceutical products. Our current portfolio of antidotes counteract certain snake venoms and the toxicity associated with some heart and cancer medications.
Did digitalis affect Van Gogh’s painting?
Van Gogh’s predilection for yellow may or may not be attributable to his epilepsy medicine. More than a century later, clinicians diagnose potentially life-threatening digoxin toxicity from specific clinical signs.
Breaking the vicious circle of snakebites in the developing world
BTG Specialty Pharmaceuticals supports Asclepius Snakebite Foundation clinic in Guinea
Covid-19 disrupted 97% of supply chains - but ours remained intact
We’re proud to have kept production running, protected our employees, and continued to deliver our products to those who need it.